Lactobacillus rhamnosus L60, a potential probiotic isolated from the human vagina
Liliana Pascual, María B. Daniele, Francisco Ruíz, Walter Giordano, Cristina Pájaro, Lucila Barberis
The Journal of General and Applied Microbiology
Abstract
The vagina has been increasingly viewed as an "ecosystem" whose normal microflora help protect it from invading pathogens, including those that cause urinary tract infections and sexually transmitted diseases. We tested new strains of lactobacilli as potential probiotics for maintenance of urogenital tract health, as well as prevention and therapy of urogenital infections. A strain of lactobacilli isolated from the vagina of nonpregnant, healthy, premenopausal women was identified as Lactobacillus rhamnosus L60 by 16S rDNA sequence homology. L60 was evaluated for antimicrobial activity, in vitro antibiotic resistance, autoaggregation, surface hydrophobicity, co-aggregation with other bacterial species, hydrogen peroxide (H(2)O(2)) production, and bacterial adherence. It displayed a wide spectrum of antimicrobial activity against urogenital pathogens, and resistance to antibiotics commonly prescribed for infections caused by these pathogens. L60 produced H(2)O(2), adhered to vaginal epithelial cells, co-aggregated with Escherichia coli and Candida albicans, and displayed self-aggregation. In view of these characteristics, L60 is considered a potential probiotic, and will be further evaluated for preventive and therapeutic application locally in the vaginal tract.
Extracted Claims
6 claims extracted from this paper into the knowledge graph
Lactobacillus rhamnosus L60 produces hydrogen peroxide (H2O2)
“L60 produced H(2)O(2)”
Lactobacillus rhamnosus L60 co-aggregates with Escherichia coli and Candida albicans
“co-aggregated with Escherichia coli and Candida albicans”
Lactobacillus rhamnosus L60 has antimicrobial activity
“displayed a wide spectrum of antimicrobial activity against urogenital pathogens”